An example of this is the dystroglycanopathies, a specific group of glycosylation defects that exclusively affect α-dystroglycan, an important component of skeletal muscle. Here, DAG1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.